Some studies have proved that Ki‐67 expression is a useful prognostic factor in breast cancer.71, 72 Our results also indicated that Ki‐67 status in post‐operative pathology IHC was the significant prognostic factor, and patients with low SII would have survive longer than those with high SII by Ki‐67 status. This evidence concerns the gene MKI67 and breast carcinoma.